The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive genomic profiling of matched ctDNA and tissue from patients with four common cancers enrolled to the NCI-MATCH trial.
 
Rini Pauly
Research Funding - Illumina (Inst)
 
Biswajit Das
Research Funding - Illumina (Inst)
 
Chris Karlovich
Research Funding - Illumina (Inst)
(OPTIONAL) Uncompensated Relationships - Illumina
 
Li Chen
Research Funding - Illumina (Inst)
Expert Testimony - Illumina (Inst)
 
Amanda Peach
Research Funding - Illumina (Inst)
 
Vishnuprabha Rahul Kannan
Research Funding - Illumina (Inst); Illumina (Inst)
 
Eric Greenbank
Research Funding - Illumina (Inst); Illumina (Inst)
 
Jennifer LoCoco
Employment - Illumina
Stock and Other Ownership Interests - CVS Health; Illumina; InhibRx
Patents, Royalties, Other Intellectual Property - Patent application pending through work performed in my role at Illumina, Inc (Inst)
 
Ting-Chia Chang
Research Funding - Illumina (Inst)
 
James Doroshow
No Relationships to Disclose
 
Lisa McShane
No Relationships to Disclose
 
Alice Chen
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst)
 
Lyndsay Harris
No Relationships to Disclose
 
Keith Flaherty
Leadership - Clovis Oncology; Khora Therapeutics; Kinnate Biopharma; Monimoi Therapeutics; Scorpion Therapeutics; Strata Oncology
Stock and Other Ownership Interests - Alterome Therapeutics; ALX Oncology; Apricity Health; Clovis Oncology; Flinr Therapeutics; FOGPharma; IntrECate; Kinnate Biopharma; Loxo; Monimoi Therapeutics; Monopteros Therapeutics; Nextech Invest; Oncoceutics; PIC Therapeutics; PreDICTA; Scorpion Therapeutics; Soley Therapeutics; Strata Oncology; Tasca Therapeutics; Transcode Therapeutics; Tvardi Therapeutics; Vibliome Therapeutics; X4 Pharma; xCures
Consulting or Advisory Role - Karkinos Healthcare; Novartis; Takeda; Tvardi Therapeutics
 
Peter O'Dwyer
Research Funding - Amgen (Inst); Array BioPharma (Inst); BBI Healthcare (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Forty Seven (Inst); Genentech (Inst); GlaxoSmithKline (Inst); H3 Biomedicine (Inst); Lilly/ImClone (Inst); Minneamrita Therapeutics (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); syndax (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); Syndax (Inst); Taiho Pharmaceutical (Inst)
 
Stanley Hamilton
Research Funding - CytoImmune Therapeutics (Inst); Intima (Inst); Iovance Biotherapeutics (Inst); Minerva Biotechnologies (Inst)
 
Traci Pawlowski
Employment - Illumina
Stock and Other Ownership Interests - BMY; Illumina; Novo Nordisk
 
Sorena Rahmanian
Employment - Illumina
Stock and Other Ownership Interests - Illumina
 
Yuri Kotliarov
No Relationships to Disclose